Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Although cases involving the issue of written description must be decided on their own facts, a detailed disclosure may provide a greater chance of meaningful patent protection for genetic innovations.
Especially for biotechnology and pharmaceutical companies, the Madrid Protocol for international trademark registration marks a new era in trademark protection.
In light of the Japan Patent Office's revised examination guidelines, what are the potential problems of protecting advanced biomedical methods related to medical activity?